HKSH Cancer Centre's Precision Targeting Technologies Leading the Evolution of "Hypofractionation"

by | PRNewswire Asia

Asia’s First Study: 5 Sessions of Proton Therapy to Control Early-Stage Prostate Cancer HONG KONG, March 20, 2026 /PRNewswire/ — HKSH Medical Group (HKSH) today announced the results of Asia’s first clinical study on early-stage prostate cancer...

Manulife Named "Asia's Best Insurance Provider for Wealth Management" by Euromoney

by | PRNewswire Asia

HONG KONG, March 20, 2026 /PRNewswire/ — Manulife today announced it has been named "Asia’s Best Insurance Provider for Wealth Management" at the 2026 Euromoney Private Banking Awards. The award recognizes Manulife’s excellence in...

Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

by | PRNewswire Asia

SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ — Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2025, and provided an update on recent business highlights and...

Professor Chun-Hung Chu: "Protecting Oral Health Is Protecting Quality of Life"

by | PRNewswire Asia

World Oral Health Day 2026:"A Happy Mouth Is… A Happy Life" HONG KONG, March 20, 2026 /PRNewswire/ — A healthy mouth is the foundation of overall well-being and plays an important role in enhancing quality of life. This year, World Oral Health Day is...

MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences

by | PRNewswire Asia

SINGAPORE, March 20, 2026 /PRNewswire/ — MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department of Pharmacy and Pharmaceutical Sciences in the...

GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer

by | PRNewswire Asia

SEOUL, South Korea, March 20, 2026 /PRNewswire/ — GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer...